192 related articles for article (PubMed ID: 28340611)
1. An exploratory cross-sectional study on the impact of education on perception of stigma by Chinese patients with schizophrenia.
Ren Z; Wang H; Feng B; Gu C; Ma Y; Chen H; Li B; Liu L
BMC Health Serv Res; 2016 Jun; 16(1):210. PubMed ID: 28340611
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional study on perception of stigma by Chinese schizophrenia patients.
Ren Z; Wang H; Feng B; Gu C; Ma Y; Chen H; Li B; Liu L
Neuropsychiatr Dis Treat; 2014; 10():535-40. PubMed ID: 24707179
[TBL] [Abstract][Full Text] [Related]
3. Stigma and discrimination experienced by people with schizophrenia living in the community in Guangzhou, China.
Li J; Guo YB; Huang YG; Liu JW; Chen W; Zhang XY; Evans-Lacko S; Thornicroft G
Psychiatry Res; 2017 Sep; 255():225-231. PubMed ID: 28582718
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative symptoms in schizophrenia and their relation to depression, anxiety, hope, self-stigma and personality traits - a cross-sectional study.
Vrbova K; Prasko J; Holubova M; Slepecky M; Ociskova M
Neuro Endocrinol Lett; 2018 Mar; 39(1):9-18. PubMed ID: 29604619
[TBL] [Abstract][Full Text] [Related]
5. Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study.
Teetharatkul T; Vitayanont A; Liabsuetrakul T; Aunjitsakul W
BMC Psychiatry; 2021 Jul; 21(1):348. PubMed ID: 34253169
[TBL] [Abstract][Full Text] [Related]
6. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
7. Equipercentile linking of the BPRS and the PANSS.
Leucht S; Rothe P; Davis JM; Engel RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW
J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
[TBL] [Abstract][Full Text] [Related]
9. Three diagnostic psychiatric subgroups in comparison to self-stigma, quality of life, disorder severity and coping management cross-sectional outpatient study.
Holubova M; Prasko J; Ociskova M; Vanek J; Slepecky M; Zatkova M; Latalova K; Kolek A
Neuro Endocrinol Lett; 2018 Oct; 39(4):331-341. PubMed ID: 30531709
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic resolution among Chinese patients with schizophrenia and associated factors.
Li CT; Su TP; Chou YH; Lee YC; Liu ME; Ku HL; Shan IK; Bai YM
J Formos Med Assoc; 2010 May; 109(5):378-88. PubMed ID: 20497871
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
Mullen J; Jibson MD; Sweitzer D
Clin Ther; 2001 Nov; 23(11):1839-54. PubMed ID: 11768836
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
14. Community-based comprehensive intervention for people with schizophrenia in Guangzhou, China: Effects on clinical symptoms, social functioning, internalized stigma and discrimination.
Li J; Huang YG; Ran MS; Fan Y; Chen W; Evans-Lacko S; Thornicroft G
Asian J Psychiatr; 2018 Apr; 34():21-30. PubMed ID: 29627721
[TBL] [Abstract][Full Text] [Related]
15. An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.
Goff DC; Posever T; Herz L; Simmons J; Kletti N; Lapierre K; Wilner KD; Law CG; Ko GN
J Clin Psychopharmacol; 1998 Aug; 18(4):296-304. PubMed ID: 9690695
[TBL] [Abstract][Full Text] [Related]
16. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
Loas G; Noisette C; Legrand A; Delahousse J
Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
[TBL] [Abstract][Full Text] [Related]
17. Internalized stigma among patients with schizophrenia in Ethiopia: a cross-sectional facility-based study.
Assefa D; Shibre T; Asher L; Fekadu A
BMC Psychiatry; 2012 Dec; 12():239. PubMed ID: 23272796
[TBL] [Abstract][Full Text] [Related]
18. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
19. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
20. Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data.
Masand P; O'Gorman C; Mandel FS
Schizophr Res; 2011 Mar; 126(1-3):174-83. PubMed ID: 21185155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
